Abstract: A battery pack is provided including at least one rechargeable secondary battery; a battery frame having a battery accommodation portion configured to accommodate the at least one secondary battery; a packaging member provided in the form of an adhesion sheet having an adhesive surface formed at one surface thereof, the packaging member including a body portion fixedly adhered to an upper portion of the secondary battery accommodated in the battery frame and a fixing portion bent and extended downward from the body portion and having the adhesive surface fixedly adhered to an outer surface of an outermost edge of the battery frame; and an anti-noise member attached to at least one portion of the adhesive surface of the packaging member.

Abstract: A method of controlling an add-on mobility includes measuring a force in a front-rear direction between a main body vehicle and the add-on mobility by a force sensor connecting the main body vehicle and the add-on mobility and controlling a driving force and a braking force of the add-on mobility according to a magnitude of the force in the front-rear direction measured by the force sensor.

Abstract: A powertrain apparatus for an electric vehicle, includes a planetary gear set including three rotation elements, a first motor connected to a first rotation element of the planetary gear set, a differential engaged to a second rotation element of the planetary gear set, a second motor connected to a third rotation element of the planetary gear set, and a synchronizer configured to selectively connect or disconnect between a driveshaft coupled to one side of the differential and the second motor and to selectively connect or disconnect between the second rotation element of the planetary gear set and the third rotation element of the planetary gear set.

Abstract: Disclosed are an anti-PD-L1 antibody or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, a pharmaceutical composition for preventing or treating cancer containing the same, and a composition for co-administration with an antibody other than an antibody binding to PD-L1, containing the same.

Abstract: Disclosed are an anti-PD-L1 antibody or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, a pharmaceutical composition for preventing or treating cancer containing the same, and a composition for co-administration with an antibody other than an antibody binding to PD-L1, containing the same.

Abstract: Disclosed is a reinforcement learning-based resource allocation method for a wireless backhaul network, which is performed by a resource allocation apparatus. The method includes estimating locations of a plurality of base stations on the basis of channel state information (CSI) measured by the plurality of base stations; and allocating resources of the wireless backhaul network to the plurality of base stations using a reinforcement learning neural network having the locations as an input.

Abstract: The present disclosure relates to an antibody specifically binding to epidermal growth factor receptor variant III (EGFRvIII), to nucleic acid coding the antibody, to a vector comprising the nucleic acid, to a host cell, to a preparation method of the antibody, and to a pharmaceutical composition comprising the antibody as an active ingredient for treating a cancer or a tumor.

Abstract: Disclosed is a reinforcement learning-based resource allocation method for a wireless backhaul network, which is performed by a resource allocation apparatus. The method includes estimating locations of a plurality of base stations on the basis of channel state information (CSI) measured by the plurality of base stations; and allocating resources of the wireless backhaul network to the plurality of base stations using a reinforcement learning neural network having the locations as an input.

Abstract: Provided is a multiple wireless network integration system and method. A software defined network (SDN) switch is connected to at least two or more networks to monitor traffic information of each network, an SDN controller provides the SDN switch with forwarding table information generated by using packet information received from the SDN switch and receives the traffic information of each network from the SDN switch to generate high-level traffic information, and an information server receives the high-level traffic information from the SDN controller to generate network state information and then detects state information of a plurality of networks accessible to a terminal and provides the detected state information to the terminal.

Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.

Abstract: Provided are an antibody specifically bound to c-Met (c-Met-specific antibody) or fragments thereof, and more specifically, a fully human antibody having high affinity and specificity to c-Met isolated from human Fv(ScFv) phage library, a polynucleotide encoding the antibody, a recombinant vector containing the polynucleotide, a cell transformed with the recombinant vector, and a method of producing the c-Met-specific antibody by culturing the cell, wherein the c-Met-specific antibody may effectively control activity of c-Met in vivo.

Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.

Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.

Abstract: The present disclosure relates to an antibody specifically binding to epidermal growth factor receptor variant III (EGFRvIII), to nucleic acid coding the antibody, to a vector comprising the nucleic acid, to a host cell, to a preparation method of the antibody, and to a pharmaceutical composition comprising the antibody as an active ingredient for treating a cancer or a tumor.

Abstract: Provided are an antibody specifically bound to c-Met (c-Met-specific antibody) or fragments thereof, and more specifically, a fully human antibody having high affinity and specificity to c-Met isolated from human Fv(ScFv) phage library, a polynucleotide encoding the antibody, a recombinant vector containing the polynucleotide, a cell transformed with the recombinant vector, and a method of producing the c-Met-specific antibody by culturing the cell, wherein the c-Met-specific antibody may effectively control activity of c-Met in vivo.

Abstract: The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.

Abstract: Provided is a Media Access Control (MAC) forwarding method for multi-hop routing in a communication system between vehicles. The method includes the steps of: a) receiving a frame from all nodes and checking whether there are duplicate frames; b) partly updating forwarding cache table (FCT) information, or updating SNT information and checking whether a destination address is a corresponding node; c) updating the FCT information, transmitting an Ack signal and transferring the frame to the upper layer, or searching whether the destination address is registered as “d_addr”; d) updating the FCT information and transmitting a delay ACK frame or checking whether the transmitted frame is a flooding frame; and e) updating the FCT information, checking whether the other node does not transmit the “d_ack” and inserting a flooding frame, otherwise, updating the FCT information and abandoning the frame.

Abstract: Method and systems are provided for diagnosing or monitoring a gastric cancer in a subject. Such methods include providing a biological sample from the subject; determining an amount in the sample of at least one biomarker, selected from the group consisting of: CDH17 and OLFM4; and comparing the amount of the at least one biomarker in the sample, if present, to a control level of the at least one biomarker. Such systems include a probe for selectively binding each of at least one biomarker.

Abstract: Provided is a Media Access Control (MAC) forwarding method for multi-hop routing in a communication system between vehicles. The method includes the steps of: a) receiving a frame from all nodes and checking whether there are duplicate frames; b) partly updating forwarding cache table (FCT) information, or updating SNT information and checking whether a destination address is a corresponding node; c) updating the FCT information, transmitting an Ack signal and transferring the frame to the upper layer, or searching whether the destination address is registered as “d_addr”; d) updating the FCT information and transmitting a delay ACK frame or checking whether the transmitted frame is a flooding frame; and e) updating the FCT information, checking whether the other node does not transmit the “d_ack” and inserting a flooding frame, otherwise, updating the FCT information and abandoning the frame.